Deep brain stimulation for psychiatric disorders: A review
Journal: JOURNAL OF BIONIC MEMORY (Vol.1, No. 2)Publication Date: 2021-11-01
Authors : Mehmet Hamid Boztas Huseyin Altug Yenice;
Page : 60-68
Keywords : Deep brain stimulation (DBS); psychiatric disorders; resistant; treatment;
Abstract
Deep Brain Stimulation (DBS) is a neurosurgical procedure via the placement of neurostimulator, which is a medical device also known as brain pacemaker. The electrical impulses, which are sent to specific targets of brain through implanted electrodes, used in the treatment of some neurological and psychiatric disorders. While the mechanisms of action of DBS on the physiology on brain cells and neurotransmitters are controversial, it is well known that high-frequency electrical impulses into specific brain areas can diminish certain symptoms of some neurological and psychiatric disorders.DBS is already approved as a treatment for several neurological disorders by theFood and Drug Administration(FDA). It is approvedas a treatment for essential tremor in 1997 andParkinson's diseasesince 2002, fordystoniain 2003 and forepilepsyin 2018. There are also variety uses of DBS in psychiatric disorders with resistance to treatment, such as obsessive compulsive disorder,Tourette's syndrome, major depressive disorder,post-traumatic stress disorder, appetite disorders, alcohol and substance use disorders and also schizophrenia. This article outlines using of deep brain stimulation as a treatment method for psychiatric disorders which are resistant to medical treatments and psychotherapies, as well as the appropriate anatomical targets and the possible mechanism of actions.
Other Latest Articles
- Port catheters:Indications, complications and quality of life
- Biliary stents: models and advancements
- Carotid artery stenting with or without distal filter-type embolic protection device: A single center experience
- ENDO CROWN: AN APPROACH FOR RESTORING ENDODONTICALLY TREATED RIGHT MANDIBULAR FIRST MOLARS WITH LARGE CORONAL DESTRUCTION- A CASE REPORT
- RISK FACTORS AND CLINICAL PROFILE OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Last modified: 2022-01-30 04:00:06